Chaisson RE - Search Results

1

Racial heterogeneity of HIV antigenemia in people with HIV infection.

Chaisson RE, Fuchs E, Stanton DL, Quinn TC, Hendricksen C, Bartlett JG, Farzadegan H. Chaisson RE, et al. AIDS. 1991 Feb;5(2):177-80. doi: 10.1097/00002030-199102000-00007. AIDS. 1991. PMID: 1903261

2

Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients.

Alwood K, Keruly J, Moore-Rice K, Stanton DL, Chaulk CP, Chaisson RE. Alwood K, et al. Among authors: chaisson re. AIDS. 1994 Aug;8(8):1103-8. doi: 10.1097/00002030-199408000-00010. AIDS. 1994. PMID: 7986406

3

Impact of the 1993 revision of the AIDS case definition on the prevalence of AIDS in a clinical setting.

Chaisson RE, Stanton DL, Gallant JE, Rucker S, Bartlett JG, Moore RD. Chaisson RE, et al. AIDS. 1993 Jun;7(6):857-62. doi: 10.1097/00002030-199306000-00015. AIDS. 1993. PMID: 8103343

4

Racial differences in the use of drug therapy for HIV disease in an urban community.

Moore RD, Stanton D, Gopalan R, Chaisson RE. Moore RD, et al. Among authors: chaisson re. N Engl J Med. 1994 Mar 17;330(11):763-8. doi: 10.1056/NEJM199403173301107. N Engl J Med. 1994. PMID: 8107743 Free article.

5

Diagnostic accuracy of three clinical case definitions for advanced HIV disease.

Gallant JE, Somani J, Chaisson RE, Stanton D, Smith M, Quinn TC. Gallant JE, et al. Among authors: chaisson re. AIDS. 1992 Mar;6(3):295-9. doi: 10.1097/00002030-199203000-00006. AIDS. 1992. PMID: 1348946

6

The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia.

Gallant JE, McAvinue SM, Moore RD, Bartlett JG, Stanton DL, Chaisson RE. Gallant JE, et al. Among authors: chaisson re. Chest. 1995 Apr;107(4):1018-23. doi: 10.1378/chest.107.4.1018. Chest. 1995. PMID: 7705108

7

Functional status of persons with HIV infection in an ambulatory setting.

Stanton DL, Wu AW, Moore RD, Rucker SC, Piazza MP, Abrams JE, Chaisson RE. Stanton DL, et al. Among authors: chaisson re. J Acquir Immune Defic Syndr (1988). 1994 Oct;7(10):1050-6. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8083822

8

Costs of HIV medical care in the era of highly active antiretroviral therapy.

Gebo KA, Chaisson RE, Folkemer JG, Bartlett JG, Moore RD. Gebo KA, et al. Among authors: chaisson re. AIDS. 1999 May 28;13(8):963-9. doi: 10.1097/00002030-199905280-00013. AIDS. 1999. PMID: 10371178

9

The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults.

Sulkowski MS, Chaisson RE, Karp CL, Moore RD, Margolick JB, Quinn TC. Sulkowski MS, et al. Among authors: chaisson re. J Infect Dis. 1998 Dec;178(6):1642-8. doi: 10.1086/314491. J Infect Dis. 1998. PMID: 9815216

10

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B, Gange S, Gallant J, Siliciano RF. Finzi D, et al. Among authors: chaisson re. Nat Med. 1999 May;5(5):512-7. doi: 10.1038/8394. Nat Med. 1999. PMID: 10229227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

444 results

Search Page